Skip to main content
FinSpry Logo
FinSpry
LYEL logo
LYEL
(NASDAQ)
Lyell Immunopharma, Inc.
$12.88-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Lyell Immunopharma (LYEL) Stock Price & Financial Analysis

Lyell Immunopharma Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$13.37 - $14.13
52-Week High$45.00
52-Week Low$11.47
Open$14.12
Volume82.29K
Average Volume (3M)141.57K
Market Cap281.76M
Shares Outstanding21.88M
Price to Sales (P/S)9089.13
Price to Book (P/B)1.03
EV/EBITDA-1.52
Revenue (TTM)31.00K
Net Income (TTM)-246.41M
Free Cash Flow (TTM)-134.42M
EPS (TTM)$-12.94
Profit Margin-794858.06%
Operating Margin-614254.84%
Return on Equity (ROE)-90.04%
Debt to Equity0.18
50-Day MA$14.09
200-Day MA$20.26
52-Week Change-2.05%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Lyell Immunopharma

What is the current stock price for LYEL?

As of the latest trading session, LYEL stock trades at $13.53. The 52-week range is $11.47–$45.00, with a day range of $13.37–$14.13.

What is the P/E ratio for LYEL?

The P/E ratio (Price-to-Earnings) for LYEL is shown in the Key Statistics section. This valuation metric helps compare Lyell Immunopharma, Inc. to industry peers.

Does LYEL pay dividends?

Lyell Immunopharma does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for LYEL?

Based on 1 analyst, the consensus for LYEL is Buy.

What is the market cap of LYEL?

Lyell Immunopharma's market capitalization is $296.0M, classifying it as a micro-cap company. Lyell Immunopharma operates in the Healthcare sector within the Biotechnology industry.